Should You Buy SIGA Technologies Inc (SIGA) Stock on Monday?

SIGA Technologies Inc (SIGA) stock has gained 1.03% over the past week and gets a Bullish rating from InvestorsObserver Sentiment Indicator.

SIGA Technologies Inc has a Bullish sentiment reading. Find out what this means for you and get the rest of the rankings on SIGA!

See Full SIGA Report

What is Stock Sentiment?

Sentiment is a very short-term indicator that is entirely technical. There is no information about the health of profitability of the underlying company in our sentiment score. As a technical indicator, news about the stock, or company, such as an earnings release or other event, could move the stock counter to the recent trend. Recent trends are a good indicator of current market sentiments. In its most basic form, stocks that are trending up are desirable by investors while stocks currently falling must be unattractive. InvestorsObserver's Sentimental Indicator tracks both changes in price and volume to analyze the most recent trends. Typically an increase in volume indicates ongoing trends are getting stronger, while a decrease in volume usually signals an end to the current trend. Available options can also represent current sentiments for a given stock. Since investors are able to bet on future trends of stocks using options, we consider the ratio of calls to puts when analyzing market sentiments .

What's Happening With SIGA Stock Today?

SIGA Technologies Inc (SIGA) stock is higher by 3.39% while the S&P 500 has fallen -0.33% as of 12:20 PM on Monday, Apr 1. SIGA has risen $0.29 from the previous closing price of $8.56 on volume of 532,825 shares. Over the past year the S&P 500 has gained 26.98% while SIGA has risen 53.91%. SIGA earned $0.95 a per share in the over the last 12 months, giving it a price-to-earnings ratio of 9.32. To see InvestorsObserver's Sentiment Score for SIGA Technologies Inc click here.

More About SIGA Technologies Inc

SIGA Technologies Inc is a commercial-stage pharmaceutical company focused on the health security market. The company's lead product is TPOXX, an orally administered antiviral drug for the treatment of human smallpox disease caused by the variola virus. Its products target orthopoxvirus infections including smallpox. Click Here to get the full Stock Report for SIGA Technologies Inc stock.